LBT in @ $0.250
LBT out @ $0.0345
A healthy 38% gain. I absolutely love these kinds of bio-med announcements, along with anything that has the words FDA approval. They are usually pump and dumps. I would have held onto LBT much longer if I had bothered to look around all the news they've attracted from this Ann - Financial review, google news etc.
But I don't understand these announcements well enough, it's not my field. So happy to make some cash.
ANQ in @ $0.004 from some other day. Chance to make serious cash with +75% gain, but decided to hold out. Next week's meeting results may be the catalyst for a re-rate. I'd rather risk walking out with only 1 pip gain than to throw away a multibagger with huge potential.
MED in @ $0.023 from yesterday. The volume, market depth and hype around incoming news is just too good for me to sell right now. This might turn into a STT with the potential to sell on news if it's not that great.
Over all a very good day for me, a mix of actual wins and wins on paper.
- Forums
- ASX - Day Trading
- Daytraders After Market Lounge 10th October
Daytraders After Market Lounge 10th October, page-11
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online